Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at ...

Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune ...

Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Manipulating the immune system to treat cancer has generated phenomenal responses in some patients, including complete cures, ...

Draft guidance published for an immunotherapy treatment that could prevent blood cancer from returning in adults who've responded well to initial therapy.

English Edition Medscape English Deutsch Español Français Português UK New Univadis ...

It's combined with bendamustine, a chemotherapy drug that damages cancer cell DNA, and rituximab, an immunotherapy drug that targets and kills cancerous B cells. Both are given through an IV and ...

When used together, these drugs can slow down or even stop the growth of the leukemia cells. In a study involving 867 patients, those who received the combination of acalabrutinib and venetoclax ...

Risk factors for chronic lymphocytic leukemia (CLL ... According to the American Cancer Society, rates of leukemia — particularly acute myeloid leukemia — are higher in workers exposed ...